[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Views 630
Citations 0
Correction
November 14, 2012

Error in Text in: Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

JAMA. 2012;308(18):1861. doi:10.1001/jama.2012.14674

Error in Text. In the Original Contribution entitled “Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial” published in the July 11, 2012, of JAMA (2012;308[2]:147-156), the median survival for the ampullary pancreatobiliary group was transposed with the median survival for the ampullary intestinal group. This article has been corrected online.

×